347 related articles for article (PubMed ID: 11467954)
21. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
Kohda D; Odaka M; Lax I; Kawasaki H; Suzuki K; Ullrich A; Schlessinger J; Inagaki F
J Biol Chem; 1993 Jan; 268(3):1976-81. PubMed ID: 8420971
[TBL] [Abstract][Full Text] [Related]
22. An analytical approach to the measurement of equilibrium binding constants: application to EGF binding to EGF receptors in intact cells measured by flow cytometry.
Stein RA; Wilkinson JC; Guyer CA; Staros JV
Biochemistry; 2001 May; 40(20):6142-54. PubMed ID: 11352752
[TBL] [Abstract][Full Text] [Related]
23. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
26. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions.
French AR; Sudlow GP; Wiley HS; Lauffenburger DA
J Biol Chem; 1994 Jun; 269(22):15749-55. PubMed ID: 8195228
[TBL] [Abstract][Full Text] [Related]
27. Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms.
Mikhailenko I; Considine W; Argraves KM; Loukinov D; Hyman BT; Strickland DK
J Cell Sci; 1999 Oct; 112 ( Pt 19)():3269-81. PubMed ID: 10504332
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics simulations of epidermal growth factor and transforming growth factor-alpha structures in water.
Watts CR; Lovas S; Murphy RF
Proteins; 1998 Nov; 33(3):396-407. PubMed ID: 9829698
[TBL] [Abstract][Full Text] [Related]
29. Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.
Hasegawa Y; Takahashi M; Ariki S; Saito A; Uehara Y; Takamiya R; Kuronuma K; Chiba H; Sakuma Y; Takahashi H; Kuroki Y
J Biol Chem; 2017 Nov; 292(45):18565-18576. PubMed ID: 28972165
[TBL] [Abstract][Full Text] [Related]
30. The role of asparagine-32 in forming the receptor-binding epitope of human epidermal growth factor.
Campion SR; Biamonti C; Montelione GT; Niyogi SK
Protein Eng; 1993 Aug; 6(6):651-9. PubMed ID: 8234236
[TBL] [Abstract][Full Text] [Related]
31. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.
Neelam B; Richter A; Chamberlin SG; Puddicombe SM; Wood L; Murray MB; Nandagopal K; Niyogi SK; Davies DE
Biochemistry; 1998 Apr; 37(14):4884-91. PubMed ID: 9538006
[TBL] [Abstract][Full Text] [Related]
32. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
[TBL] [Abstract][Full Text] [Related]
33. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
[TBL] [Abstract][Full Text] [Related]
34. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
Sanders JM; Wampole ME; Thakur ML; Wickstrom E
PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
[TBL] [Abstract][Full Text] [Related]
35. Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32.
Koide H; Muto Y; Kasai H; Hoshi K; Takusari H; Kohri K; Takahashi S; Sasaki T; Tsukumo K; Miyake T
FEBS Lett; 1992 May; 302(1):39-42. PubMed ID: 1587350
[TBL] [Abstract][Full Text] [Related]
36. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
[TBL] [Abstract][Full Text] [Related]
37. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity.
van de Poll ML; van Vugt MJ; Lenferink AE; van Zoelen EJ
Biochemistry; 1997 Jun; 36(24):7425-31. PubMed ID: 9200690
[TBL] [Abstract][Full Text] [Related]
38. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
39. Endogenous ligands for the epidermal growth factor receptor in human breast tumors do not interfere in an epidermal growth factor receptor radioligand binding assay.
Kienhuis CB; Koenders PG; Klominska H; Benraad TJ
Breast Cancer Res Treat; 1993 Sep; 27(3):271-5. PubMed ID: 8312585
[TBL] [Abstract][Full Text] [Related]
40. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
